메뉴 건너뛰기




Volumn 69, Issue 4, 2017, Pages 463-464

Cangrelor Use Since FDA Approval: A Single-Center, Real-World Experience at a Tertiary Care Hospital

Author keywords

[No Author keywords available]

Indexed keywords

CANGRELOR; ADENOSINE PHOSPHATE; PURINERGIC P2Y RECEPTOR ANTAGONIST;

EID: 85007480717     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.11.017     Document Type: Letter
Times cited : (21)

References (3)
  • 1
    • 84875779761 scopus 로고    scopus 로고
    • Effect of platelet inhibition with cangrelor during PCI on ischemic events
    • 1 Bhatt, D.L., Stone, G.W., Mahaffey, K.W., et al. Effect of platelet inhibition with cangrelor during PCI on ischemic events. N Engl J Med 368 (2013), 1303–1313.
    • (2013) N Engl J Med , vol.368 , pp. 1303-1313
    • Bhatt, D.L.1    Stone, G.W.2    Mahaffey, K.W.3
  • 2
    • 84890136652 scopus 로고    scopus 로고
    • Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data
    • 2 Steg, P.G., Bhatt, D.L., Hamm, C.W., et al. Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data. Lancet 382 (2013), 1981–1992.
    • (2013) Lancet , vol.382 , pp. 1981-1992
    • Steg, P.G.1    Bhatt, D.L.2    Hamm, C.W.3
  • 3
    • 85008627203 scopus 로고    scopus 로고
    • Cangrelor with and without glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention
    • 3 Vaduganathan, M., Harrington, R.A., Stone, G.W., et al. Cangrelor with and without glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol 69 (2017), 176–185.
    • (2017) J Am Coll Cardiol , vol.69 , pp. 176-185
    • Vaduganathan, M.1    Harrington, R.A.2    Stone, G.W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.